Glenmark’s novel monoclonal antibody GBR 900 enters human trials
GBR 900 is a first in class monoclonal antibody for the treatment of chronic pain targeting TrkA, the receptor of NGF
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 470
Browsing Category
Latest Updates
“Full immunisation is the birthright of every child”
Disease is an event, but prevented disease is a non-event. National Immunisation Week (April 24 to 30) is the appropriate time to…
Mylan challenges FDA ruling on Celecoxib exclusivity
Believes that the FDA has seriously erred in its decision in this case Mylan Inc. (Nasdaq: MYL) announced that it has filed suit…
Bilcare receives National Intellectual Property Award 2014 by GoI
Developed path-breaking technology solution - nonClonableID technology with over 200 patent applications and 36 granted patents…
FDA approves first human papillomavirus test for primary cervical cancer screening
The cobas HPV test is manufactured by Roche Molecular Systems
Jubilant Life Sciences receives ANDA approval
Spironolactone is the generic version of Aldactone®(of GD Searle) Jubilant Life Sciences Ltd, an integrated Pharmaceuticals and…
Novartis granted injunctions against four other generic makers over Galvus
Novartis filed an RTI with the DCGIseeking information regarding regulatory approvals issued for Vildagliptin
Lonza appoints Marc Funk as COO of the Pharma & Biotech segment
Funk has been the Group’s Chief Legal Officer and Board Secretary since 2009
Oviya MedSafe partners with Assured Information Systems
Strategic alliance offers cost-effective regulatory-compliant global pharmacovigilance support
Quintiles and Biogen Idec in partnership
The five-year collaboration is designed to leverage the expertise and experience from both organisations to optimise Biogen Idec’s…